Storys zum Thema Chemie

STADA Arzneimittel AG

Press Release: EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar

EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar - STADA announces EMA acceptance of Marketing Authorization Applications for AVT03, a proposed denosumab biosimilar to Prolia® (Bone Health) and Xgeva® (Oncology) - STADA holds marketing rights for AVT03 in Europe, as well ...

Obrist Group

Obrist Group Now Open for Institutional Investors

Epitomee Medical

Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device

Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially ...

Scantox A/S

Scantox Group acquires Gentronix, a world leader in genetic toxicology

Ejby, Denmark (ots/PRNewswire) - Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into Scantox Group, is well recognized for its high-quality genetic toxicology services and strong scientific engagement, with ...

hubergroup Deutschland GmbH

6

Press Release - hubergroup is Cradle to Cradle certified for the fourth time in a row

PCC SE

PCC BakkiSilicon hf. receives ISCC Carbon Footprint Certification for critical raw material silicon / PCC subsidiary becomes first silicon producer to receive ISCC certification for carbon footprint

nova-Institut GmbH

5

Advanced Recycling Conference 2024: New Focus Areas and Innovative Program Announced

nova-Institut GmbH

4

CO₂-based Fuels and Chemicals Conference 2025 – Call for Abstracts and Posters

Acousia Therapeutics GmbH

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...

OCI Global

OCI Global Announces Agreement for the Sale of its Clean Ammonia Project in Beaumont, Texas to Woodside Energy

Amsterdam (ots/PRNewswire) - - OCI Global ("OCI") has entered into a binding equity purchase agreement for the sale of 100% of its equity interests in OCI's 1.1 million metric tonnes Clean Ammonia project under construction in Beaumont, Texas ("OCI Clean Ammonia" or the "Project"), (the "Transaction") to Woodside ...

Technische Universität München

What gave the first molecules their stability?

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE New insights into the origins of life What gave the first molecules their stability? • Until now, it was unclear how complex molecules could survive in the primordial soup• Unstable RNA molecules are stabilized by double strands • RNAs may be able to form their own complementary strand The origins of life remain a major mystery. How were complex molecules able to form and ...

Grünenthal Group

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...

Hydrogenious LOHC Technologies GmbH

IPCEI: Hydrogenious LOHC receives multi-million grant for Green Hydrogen @ Blue Danube

Aurubis AG

3

Press release: Largest planned maintenance shutdown at Aurubis Hamburg plant successfully concluded

hubergroup Deutschland GmbH

7

Press Release - Eurosyn announces Strategic Partnership with hubergroup Chemicals

Gerresheimer AG

10

Gerresheimer: New pictures available

LAUDA DR. R. WOBSER GMBH & CO. KG

5

ACHEMA 2024: LAUDA Looks Back on a Successful Exhibition

Koehler Group

An era comes to an end: Last piece of coal fired at Oberkirch combined heat and power plant

Aurubis AG

2

Press release: More strategic metals for Europe: Aurubis commissions modernized tankhouse in Lünen

Biesterfeld AG

2

Biesterfeld Group acquires Aerontec and expands its presence in Africa

Soterios Pharma

Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

London (ots/PRNewswire) - - Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo ...

Lamilux Heinrich Strunz GmbH

3

Red Dot Design Award for LAMILUX Modular Glass Skylight MS78

Gerresheimer AG

Gerresheimer expands capacities for Medical Systems in the USA

Technische Universität München

Multi-purpose mucus - What mucins can do in medicine

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE What mucins can do in medicine Multi-purpose mucus They are in our eyes, on our tongues, and in our stomachs: Protective layers of mucus, a slime consisting primarily of mucins. These are molecules which bind water to form a natural lubricant. Researchers at the Technical University of Munich (TUM) use them to develop coatings for contact lenses and intubation tubes, healing ...